ZK INTERNATIONAL GROUP CO LT (ZKIN) Stock Fundamental Analysis

NASDAQ:ZKIN • VGG9892K2092

1.13 USD
-0.16 (-12.4%)
Last: Mar 2, 2026, 11:45 AM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

1

ZKIN gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 157 industry peers in the Metals & Mining industry. Both the profitability and financial health of ZKIN have multiple concerns. ZKIN is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • ZKIN had negative earnings in the past year.
  • ZKIN had a positive operating cash flow in the past year.
  • ZKIN had negative earnings in each of the past 5 years.
  • ZKIN had negative operating cash flow in 4 of the past 5 years.
ZKIN Yearly Net Income VS EBIT VS OCF VS FCFZKIN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -20M -40M -60M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -6.34%, ZKIN is doing worse than 63.06% of the companies in the same industry.
  • ZKIN has a worse Return On Equity (-16.27%) than 68.79% of its industry peers.
Industry RankSector Rank
ROA -6.34%
ROE -16.27%
ROIC N/A
ROA(3y)-37.96%
ROA(5y)-24.29%
ROE(3y)-89.87%
ROE(5y)-56.22%
ROIC(3y)N/A
ROIC(5y)N/A
ZKIN Yearly ROA, ROE, ROICZKIN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100 -150 -200

1.3 Margins

  • Looking at the Gross Margin, with a value of 5.67%, ZKIN is doing worse than 62.42% of the companies in the same industry.
  • In the last couple of years the Gross Margin of ZKIN has grown nicely.
  • The Profit Margin and Operating Margin are not available for ZKIN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 5.67%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.58%
GM growth 5Y4.77%
ZKIN Yearly Profit, Operating, Gross MarginsZKIN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 -40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. Health

2.1 Basic Checks

  • ZKIN does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, ZKIN has more shares outstanding
  • The number of shares outstanding for ZKIN has been increased compared to 5 years ago.
  • The debt/assets ratio for ZKIN is higher compared to a year ago.
ZKIN Yearly Shares OutstandingZKIN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M
ZKIN Yearly Total Debt VS Total AssetsZKIN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

2.2 Solvency

  • Based on the Altman-Z score of 0.47, we must say that ZKIN is in the distress zone and has some risk of bankruptcy.
  • ZKIN has a worse Altman-Z score (0.47) than 85.35% of its industry peers.
  • ZKIN has a debt to FCF ratio of 324.85. This is a negative value and a sign of low solvency as ZKIN would need 324.85 years to pay back of all of its debts.
  • With a Debt to FCF ratio value of 324.85, ZKIN perfoms like the industry average, outperforming 54.14% of the companies in the same industry.
  • A Debt/Equity ratio of 0.47 indicates that ZKIN is not too dependend on debt financing.
  • ZKIN has a Debt to Equity ratio of 0.47. This is in the lower half of the industry: ZKIN underperforms 70.70% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 324.85
Altman-Z 0.47
ROIC/WACCN/A
WACC7.67%
ZKIN Yearly LT Debt VS Equity VS FCFZKIN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M 40M 60M 80M

2.3 Liquidity

  • A Current Ratio of 1.44 indicates that ZKIN should not have too much problems paying its short term obligations.
  • With a Current ratio value of 1.44, ZKIN is not doing good in the industry: 73.89% of the companies in the same industry are doing better.
  • ZKIN has a Quick Ratio of 1.02. This is a normal value and indicates that ZKIN is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.02, ZKIN is doing worse than 68.79% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.44
Quick Ratio 1.02
ZKIN Yearly Current Assets VS Current LiabilitesZKIN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. Growth

3.1 Past

  • The earnings per share for ZKIN have decreased strongly by -24.19% in the last year.
  • Looking at the last year, ZKIN shows a very negative growth in Revenue. The Revenue has decreased by -34.16% in the last year.
  • ZKIN shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -3.87% yearly.
EPS 1Y (TTM)-24.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-20.56%
Revenue 1Y (TTM)-34.16%
Revenue growth 3Y-11.39%
Revenue growth 5Y-3.87%
Sales Q2Q%-43.51%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ZKIN Yearly Revenue VS EstimatesZKIN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • ZKIN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ZKIN Price Earnings VS Forward Price EarningsZKIN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

  • ZKIN's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 231.22
EV/EBITDA N/A
ZKIN Per share dataZKIN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for ZKIN!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ZK INTERNATIONAL GROUP CO LT

NASDAQ:ZKIN (3/2/2026, 11:45:21 AM)

1.13

-0.16 (-12.4%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)02-16
Earnings (Next)N/A
Inst Owners0%
Inst Owner Change0%
Ins Owners0.03%
Ins Owner ChangeN/A
Market Cap19.52M
Revenue(TTM)71.24M
Net Income(TTM)-3.99M
Analysts0
Price TargetN/A
Short Float %0.32%
Short Ratio2.28
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.27
P/FCF 231.22
P/OCF 26.5
P/B 0.8
P/tB 0.84
EV/EBITDA N/A
EPS(TTM)-0.67
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFY0.43%
OCF(TTM)0.04
OCFY3.77%
SpS4.13
BVpS1.42
TBVpS1.35
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -6.34%
ROE -16.27%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 5.67%
FCFM 0.12%
ROA(3y)-37.96%
ROA(5y)-24.29%
ROE(3y)-89.87%
ROE(5y)-56.22%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.58%
GM growth 5Y4.77%
F-Score3
Asset Turnover1.13
Health
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 324.85
Debt/EBITDA N/A
Cap/Depr 75.02%
Cap/Sales 0.92%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.44
Quick Ratio 1.02
Altman-Z 0.47
F-Score3
WACC7.67%
ROIC/WACCN/A
Cap/Depr(3y)127.07%
Cap/Depr(5y)145.32%
Cap/Sales(3y)1.18%
Cap/Sales(5y)1.55%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-24.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-20.56%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-34.16%
Revenue growth 3Y-11.39%
Revenue growth 5Y-3.87%
Sales Q2Q%-43.51%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-124%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y101.13%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y110.71%
OCF growth 3YN/A
OCF growth 5Y9.87%

ZK INTERNATIONAL GROUP CO LT / ZKIN FAQ

Can you provide the ChartMill fundamental rating for ZK INTERNATIONAL GROUP CO LT?

ChartMill assigns a fundamental rating of 1 / 10 to ZKIN.


What is the valuation status of ZK INTERNATIONAL GROUP CO LT (ZKIN) stock?

ChartMill assigns a valuation rating of 1 / 10 to ZK INTERNATIONAL GROUP CO LT (ZKIN). This can be considered as Overvalued.


Can you provide the profitability details for ZK INTERNATIONAL GROUP CO LT?

ZK INTERNATIONAL GROUP CO LT (ZKIN) has a profitability rating of 1 / 10.